Cargando…
Nebulized mesenchymal stem cell derived conditioned medium ameliorates Escherichia coli induced pneumonia in a rat model
BACKGROUND: Mesenchymal stem cells (MSC) have shown immense therapeutic promise in a range of inflammatory diseases, including acute respiratory distress syndrome (ARDS), and are rapidly advancing through clinical trials. Among their multimodal mechanisms of action, MSCs exert strong immunomodulator...
Autores principales: | González, Héctor E., McCarthy, Sean D., Masterson, Claire, Laffey, John G., MacLoughlin, Ronan, O’Toole, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272576/ https://www.ncbi.nlm.nih.gov/pubmed/37332742 http://dx.doi.org/10.3389/fmed.2023.1162615 |
Ejemplares similares
-
Aerosolized Pulmonary Delivery of mRNA Constructs Attenuates Severity of Escherichia coli Pneumonia in the Rat
por: McCarthy, Sean D., et al.
Publicado: (2023) -
Nebulised mesenchymal stem cell derived extracellular vesicles ameliorate E. coli induced pneumonia in a rodent model
por: Gonzalez, Hector, et al.
Publicado: (2023) -
Multiple Dosing and Preactivation of Mesenchymal Stromal Cells Enhance Efficacy in Established Pneumonia Induced by Antimicrobial-Resistant Klebsiella pneumoniae in Rodents
por: Byrnes, Declan, et al.
Publicado: (2023) -
Delayed MSC therapy enhances resolution of organized pneumonia induced by antibiotic resistant Klebsiella pneumoniae infection
por: Byrnes, Declan, et al.
Publicado: (2023) -
Inhibition of pulmonary nuclear factor kappa-B decreases the severity of acute Escherichia coli pneumonia but worsens prolonged pneumonia
por: Devaney, James, et al.
Publicado: (2013)